Stock Events

Stock Events

NewAmsterdam Pharma Company NV (NAMS) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.93

-0.68

-0.43

-0.18

Details

Expected EPS

-0.491965

Actual EPS

-0.340383

Surprise EPS

0.15

Surprise Percent

+30.81%

Description

NewAmsterdam Pharma Company NV (NAMS) has reported earnings of -0.340383 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.